The purpose of this study is to evaluate the capacity of some novels biomarkers Procalcitonin (PCT), Midregional Proadrenomedullin (MR pro ADM), Midregional pro-atrial natriuretic peptide (MR pro ANP), Copeptin (CT pro arginine vasopressin), Pro endothelin to stratify the risk in severe dyspnea.
In emergency department shortness of breath (SOB)is a common symptom and its cause is not easy to be identified. The risk stratifying remains a challenge, Prognostic value of biomarkers might be helpful.
Study Type
OBSERVATIONAL
Enrollment
444
Mr pro ADM, Mr pro ANP, PCT, Copeptin and pro endothelin value to stratify the risk in SOB patients
Emergency department of Pitié Salpetriere Hospital
Paris, Paris, France
prognostic value of PCT, MR proADM, Mr pro ANP, Copeptin and pro endothelin in SOB
all cause mortality or Intensive Care Unit(ICU) admission from inclusion to Day 30
Time frame: at Day 30
establish the diagnostic value of PCT and MR pro ANP
Confirm the diagnostic value of PCT and it's level in sepsis and MR pro ANP in Heart failure
Time frame: at admission
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.